| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T1 |
0-92 |
Sentence |
denotes |
Differential selectivity of hyaluronidase inhibitors toward acidic and basic hyaluronidases. |
| T1 |
0-92 |
Sentence |
denotes |
Differential selectivity of hyaluronidase inhibitors toward acidic and basic hyaluronidases. |
| T1 |
0-92 |
Sentence |
denotes |
Differential selectivity of hyaluronidase inhibitors toward acidic and basic hyaluronidases. |
| TextSentencer_T2 |
93-263 |
Sentence |
denotes |
Hyaluronidase (HAase), a class of enzymes which degrade hyaluronic acid (HA), are involved in the spread of infections/toxins, ovum fertilization, and cancer progression. |
| T2 |
93-263 |
Sentence |
denotes |
Hyaluronidase (HAase), a class of enzymes which degrade hyaluronic acid (HA), are involved in the spread of infections/toxins, ovum fertilization, and cancer progression. |
| T2 |
93-263 |
Sentence |
denotes |
Hyaluronidase (HAase), a class of enzymes which degrade hyaluronic acid (HA), are involved in the spread of infections/toxins, ovum fertilization, and cancer progression. |
| TextSentencer_T3 |
264-322 |
Sentence |
denotes |
Thus, HAase inhibitors may have use in disease treatments. |
| T3 |
264-322 |
Sentence |
denotes |
Thus, HAase inhibitors may have use in disease treatments. |
| T3 |
264-322 |
Sentence |
denotes |
Thus, HAase inhibitors may have use in disease treatments. |
| TextSentencer_T4 |
323-418 |
Sentence |
denotes |
We evaluated 21 HAase inhibitors against HYAL-1, testicular, honeybee, and Streptomyces HAases. |
| T4 |
323-418 |
Sentence |
denotes |
We evaluated 21 HAase inhibitors against HYAL-1, testicular, honeybee, and Streptomyces HAases. |
| T4 |
323-418 |
Sentence |
denotes |
We evaluated 21 HAase inhibitors against HYAL-1, testicular, honeybee, and Streptomyces HAases. |
| TextSentencer_T5 |
419-634 |
Sentence |
denotes |
Among these inhibitors, polymers of poly (styrene-4-sulfonate) (PSS) (i.e., molecular weight 1400-990,000 or PSS 1400-PSS 990,000) and O-sulfated HA (sHA) derivatives (sHA2.0, 2.5, and 2.75) were the most effective. |
| T5 |
419-634 |
Sentence |
denotes |
Among these inhibitors, polymers of poly (styrene-4-sulfonate) (PSS) (i.e., molecular weight 1400-990,000 or PSS 1400-PSS 990,000) and O-sulfated HA (sHA) derivatives (sHA2.0, 2.5, and 2.75) were the most effective. |
| T5 |
419-634 |
Sentence |
denotes |
Among these inhibitors, polymers of poly (styrene-4-sulfonate) (PSS) (i.e., molecular weight 1400-990,000 or PSS 1400-PSS 990,000) and O-sulfated HA (sHA) derivatives (sHA2.0, 2.5, and 2.75) were the most effective. |
| TextSentencer_T6 |
635-825 |
Sentence |
denotes |
HYAL-1 and bee HAases were the most sensitive, followed by testicular HAase; Streptomyces HAase was resistant to all inhibitors, except PSS 990,000 and VERSA-TL 502 (i.e., PSS 10(6) dalton). |
| T6 |
635-825 |
Sentence |
denotes |
HYAL-1 and bee HAases were the most sensitive, followed by testicular HAase; Streptomyces HAase was resistant to all inhibitors, except PSS 990,000 and VERSA-TL 502 (i.e., PSS 10(6) dalton). |
| T6 |
635-825 |
Sentence |
denotes |
HYAL-1 and bee HAases were the most sensitive, followed by testicular HAase; Streptomyces HAase was resistant to all inhibitors, except PSS 990,000 and VERSA-TL 502 (i.e., PSS 10(6) dalton). |
| TextSentencer_T7 |
826-917 |
Sentence |
denotes |
The length of the PSS polymer determined their potency (e.g., IC50 for HYAL-1, PSS 990,000: |
| T7 |
826-917 |
Sentence |
denotes |
The length of the PSS polymer determined their potency (e.g., IC50 for HYAL-1, PSS 990,000: |
| T7 |
826-917 |
Sentence |
denotes |
The length of the PSS polymer determined their potency (e.g., IC50 for HYAL-1, PSS 990,000: |
| TextSentencer_T8 |
918-995 |
Sentence |
denotes |
0.0096 microM; PSS 210 no inhibition; IC50 for testicular HAase, PSS 990,000: |
| T8 |
918-995 |
Sentence |
denotes |
0.0096 microM; PSS 210 no inhibition; IC50 for testicular HAase, PSS 990,000: |
| T8 |
918-995 |
Sentence |
denotes |
0.0096 microM; PSS 210 no inhibition; IC50 for testicular HAase, PSS 990,000: |
| TextSentencer_T9 |
996-1033 |
Sentence |
denotes |
0.042 microM; PSS 210 no inhibition). |
| T9 |
996-1033 |
Sentence |
denotes |
0.042 microM; PSS 210 no inhibition). |
| T9 |
996-1033 |
Sentence |
denotes |
0.042 microM; PSS 210 no inhibition). |
| TextSentencer_T10 |
1034-1199 |
Sentence |
denotes |
The presence, but not the number, of sulfate groups on the sHA molecule determined its potency (e.g., IC50 for HYAL-1: sHA2.0, 0.019 microM; sHA2.75, 0.0083 microM). |
| T10 |
1034-1199 |
Sentence |
denotes |
The presence, but not the number, of sulfate groups on the sHA molecule determined its potency (e.g., IC50 for HYAL-1: sHA2.0, 0.019 microM; sHA2.75, 0.0083 microM). |
| T10 |
1034-1199 |
Sentence |
denotes |
The presence, but not the number, of sulfate groups on the sHA molecule determined its potency (e.g., IC50 for HYAL-1: sHA2.0, 0.019 microM; sHA2.75, 0.0083 microM). |
| TextSentencer_T11 |
1200-1342 |
Sentence |
denotes |
Other known HAase inhibitors, such as gossypol, sodium-aurothiomalate, 1-tetradecane sulfonic acid, and glycerrhizic acid, were not effective. |
| T11 |
1200-1342 |
Sentence |
denotes |
Other known HAase inhibitors, such as gossypol, sodium-aurothiomalate, 1-tetradecane sulfonic acid, and glycerrhizic acid, were not effective. |
| T11 |
1200-1342 |
Sentence |
denotes |
Other known HAase inhibitors, such as gossypol, sodium-aurothiomalate, 1-tetradecane sulfonic acid, and glycerrhizic acid, were not effective. |
| TextSentencer_T12 |
1343-1534 |
Sentence |
denotes |
Both PSS and sHA inhibited HAases by a mixed inhibition mechanism (i.e., competitive + uncompetitive) and were 5- to 17-fold better as uncompetitive inhibitors than as competitive inhibitors. |
| T12 |
1343-1534 |
Sentence |
denotes |
Both PSS and sHA inhibited HAases by a mixed inhibition mechanism (i.e., competitive + uncompetitive) and were 5- to 17-fold better as uncompetitive inhibitors than as competitive inhibitors. |
| T12 |
1343-1534 |
Sentence |
denotes |
Both PSS and sHA inhibited HAases by a mixed inhibition mechanism (i.e., competitive + uncompetitive) and were 5- to 17-fold better as uncompetitive inhibitors than as competitive inhibitors. |
| TextSentencer_T13 |
1535-1743 |
Sentence |
denotes |
These results demonstrate that HAase inhibitors show selectivity toward the different types of HAases, which could be exploited to inhibit specific HAases involved in a variety of pathophysiologic conditions. |
| T13 |
1535-1743 |
Sentence |
denotes |
These results demonstrate that HAase inhibitors show selectivity toward the different types of HAases, which could be exploited to inhibit specific HAases involved in a variety of pathophysiologic conditions. |
| T13 |
1535-1743 |
Sentence |
denotes |
These results demonstrate that HAase inhibitors show selectivity toward the different types of HAases, which could be exploited to inhibit specific HAases involved in a variety of pathophysiologic conditions. |